Phase 3 Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus Interventions: Drug: TG103; Drug: Dulaglutide Sponsors: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Magnetic Jejuno-Ileal Diversion Study ( " MJI Study " )
Conditions: Obesity; Type 2 Diabetes Interventions: Device: Magnet System, DI Biofragmentable Sponsors: GT Metabolic Solutions, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Endogenex Receives IDE Approval to Initiate Pivotal Clinical Study
MINNEAPOLIS, Jan. 30, 2024. Endogenex, Inc., a clinical stage medical device company dedicated to improving outcomes in patients with Type 2 Diabetes (T2D), announced that the U.S. Food and Drug Administration (FDA) granted an Investigational Device... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 31, 2024 Category: Pharmaceuticals Source Type: clinical trials
Changes in Hematological Parameters With Glycemia Control in Type 2 Diabetes
Conditions: Poorly Controlled Diabetes Mellitus Sponsors: Goztepe Prof Dr Suleyman Yalc ın City Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Mindful Eating and Current Glycemic Control in Patients With Type 2 Diabetes
Conditions: Type 2 Diabetes Sponsors: Goztepe Prof Dr Suleyman Yalc ın City Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Increased Blood Glucose Levels After Steroid Injection
Conditions: Osteoarthritis, Knee; Diabete Type 2 Interventions: Drug: steroid (triamcinolone) Sponsors: Syrian Private University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of " BR1019 " and Co-administration of " BR1019-1 " and " BR1019-2 "
Conditions: Type 2 Diabetes Mellitus; Essential Hypertension Interventions: Drug: BR1019; Drug: BR1019-1; Drug: BR1019-2 Sponsors: Boryung Pharmaceutical Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
Multicomponent Intervention on Lifestyle, Anthropometric Measurements, Glycemic Control and Quality of Life in Patients Obese People With Type II Diabetes
Conditions: Obesity; Diabetes Mellitus, Type 2 Interventions: Behavioral: Group session 1; Behavioral: Group session 2; Behavioral: Group session 3; Behavioral: Group session 4; Behavioral: Group session 5; Behavioral: Group session 6; Behavioral: Group session 7 to 8; Behavioral: Group session 9; Behavioral: Control Intervention 1; Behavioral: Control Intervention 2; Behavioral: Control Intervention 3; Behavioral: Control Intervention 4 Sponsors: Castilla-La Mancha Health Service Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Effect of Periodontal Treatment on Adipokine Levels
Conditions: Periodontitis; Diabetes Mellitus, Type 2 Interventions: Procedure: Non-surgical periodontal treatment Sponsors: Marmara University; University of Turku Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Effect of Cryolipolysis on Insulin Resistance
Conditions: Type 2 Diabetes Mellitus in Obese; Cryotherapy Effect Interventions: Procedure: Cryolipolysis Sponsors: Cairo University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy
Conditions: Diabetic Nephropathies; Type 2 Diabetes Interventions: Drug: Pirfenidone; Other: Placebo Sponsors: Sidrah Lodhi Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
The Effects of Calisthenic Exercise Training in Patients With Type 2 Diabetes
Conditions: Type 2 Diabetes Interventions: Other: Calisthenic exercise training with telerehabilitation; Other: Control Group Sponsors: Gazi University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Conditions: Type 2 Diabetes Interventions: Drug: Cagrilintide; Drug: Semaglutide; Drug: Tirzepatide Sponsors: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy
Conditions: Essential Hypertension; Type 2 Diabetes Mellitus Interventions: Drug: BR1019A; Drug: BR1019B; Drug: BR1019C; Drug: BR1019A-1; Drug: BR1019B-1; Drug: BR1019C-1 Sponsors: Boryung Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.
Conditions: Diabetic Nephropathy Type 2 Interventions: Drug: Dorzagliatin; Drug: Gliclazide Sponsors: Yan Bi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
